These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1865415)

  • 1. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats.
    Hayashi M; Matsunaga K; Okahara A; Mita S
    J Rheumatol; 1991 May; 18(5):691-5. PubMed ID: 1865415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
    Aono H; Hasunuma T; Fujisawa K; Nakajima T; Yamamoto K; Mita S; Nishioka K
    J Rheumatol; 1996 Jan; 23(1):65-70. PubMed ID: 8838510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bucillamine, a new anti-rheumatic drug, on the experimental autoimmune uveitis in rats.
    Sawa K; Mochizuki M
    Exp Eye Res; 1994 Apr; 58(4):431-8. PubMed ID: 7925680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
    Morinobu A; Wang Z; Kumagai S
    J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites.
    Hashimoto K; Lipsky PE
    J Rheumatol; 1993 Jun; 20(6):953-7. PubMed ID: 8350330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats.
    García-González A; Lotz M; Ochoa JL
    Rev Invest Clin; 2009; 61(3):212-20. PubMed ID: 19736810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.
    Setoguchi C; Tsuji F; Katsuta O; Okamoto M; Aono H
    Mod Rheumatol; 2010 Aug; 20(4):381-8. PubMed ID: 20379758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].
    Fujimura H; Hiramatsu Y; Tamura Y; Yanagihara M; Koda A; Nagai H; Uda K; Iso T; Yamauchi H
    Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benoxaprofen on the inflammatory, humoral and cellular components of type II collagen-induced arthritis in rats.
    Phadke K; Nanda S
    Eur J Rheumatol Inflamm; 1982; 5(2):170-4. PubMed ID: 6979480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
    Mita S; Matsunaga K
    Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effect of bucillamine (SA96) on interleukin-1-and/or -2-induced proliferation of T lymphocytes.
    Sasano M; Goto M; Nishioka K
    Agents Actions; 1990 Nov; 31(3-4):285-9. PubMed ID: 2085145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
    Phadke K; Carroll J; Nanda S
    Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
    Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
    Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats.
    Hirano S; Wakazono K; Agata N; Mase T; Yamamoto R; Matsufuji M; Sakata N; Iguchi H; Tone H; Ishizuka M
    Int J Tissue React; 1994; 16(4):155-62. PubMed ID: 7797401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs--the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug.
    Matsuno H; Sugiyama E; Muraguchi A; Nezuka T; Kubo T; Matsuura K; Tsuji H
    Int J Immunopharmacol; 1998 Jun; 20(6):295-304. PubMed ID: 9754677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin on secretory function of synoviocytes from adjuvant arthritis rats.
    Wang B; Chen MZ
    Int J Tissue React; 1998; 20(3):91-4. PubMed ID: 9894181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
    Nakata K; Suda H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of the type II collagen protein from Zaocys on cytokines production by synoviocytes in rats with adjuvant arthritis].
    Pang J; Li J; Wu XH; Wu HY
    Zhong Yao Cai; 2009 Apr; 32(4):556-60. PubMed ID: 19645241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.